Skip to main content
. 2011 May 18;6(5):e19566. doi: 10.1371/journal.pone.0019566

Table 2. Causes of serious clinical events during 6 months follow-up on antituberculous treatment in 167 HIV-infected and 86 HIV-uninfected individuals.

HIV-infected (nā€Š=ā€Š167) HIV-uninfected (nā€Š=ā€Š86)
Total number of serious adverse events
in number of patients (pat) 77 events in 58 pat 6 events in 6 pat
Concomitant infection 31 (19%) 2 (2%)
Confirmed infectiona 9 -
Suspected infectionb 22 2
Drug-induced liver toxicity 22 (13%) 2 (2%)
Paradoxical reactions/TB IRIS c 21 (13%) 1 (1%)
probable 12 1
possible 9 -
Treatment failure (multidrug-resistant TB) - 1 (1%)
Miscellanous 5 (3%) -
Suspected lymphoma 2 -
Suspected Kaposi's sarcoma 1 -
a

illnesses with identified etiologic agent were: Klebsiella pneumoniae bacteremia (2), Staphylococcus aureus bacteremia (1), Klebsiella pneumoniae urosepsis (2), cryptococcal meningitis (1), zona ophtalmica (1), Plasmodium falciparum malaria (1), Escherichia coli dysentery (1).

b

in most cases no etiologic agent was identified including ilnesses such as hepatic abscess, enteritis, cholangitis, bronchopneumonia, urosepsis.

c

immune reconstitution inflammatory syndrome (IRIS) is used according to consensus case definitions for resource-limited countries [16]; paradoxical reaction is the term used for HIV-uninfected persons.